XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 1,047,050,000 $ 1,006,564,000
Cost of revenue 503,009,000 515,874,000
Gross profit 544,041,000 490,690,000
Operating expenses:    
Research and development 251,615,000 238,595,000
Sales and marketing 214,018,000 259,885,000
General and administrative 111,966,000 112,568,000
Restructuring costs 9,946,000 121,942,000
Impairment of long-lived assets 0 21,784,000
Total operating expenses 587,545,000 754,774,000
Loss from operations (43,504,000) (264,084,000)
Other expenses, net:    
Share of losses from equity method investment (29,575,000) (30,419,000)
Impairment of strategic investments 0 (46,154,000)
Other income, net 27,918,000 8,985,000
Total other expenses, net (1,657,000) (67,588,000)
Loss before provision for income taxes (45,161,000) (331,672,000)
Provision for income taxes (10,188,000) (10,467,000)
Net loss attributable to common stockholders $ (55,349,000) $ (342,139,000)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.31) $ (1.84)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.31) $ (1.84)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 181,017,726 186,403,349
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 181,017,726 186,403,349